Petco Health And Wellness Company, Inc. · NASDAQ:WOOF

Petco Health And Wellness — Q1 2026 Earnings Presentation

16 slides from Petco Health And Wellness's earnings presentation, Jun 3, 2026

  1. Slide 1: First Quarter 2026 Financial Highlights

    First Quarter 2026 Financial Highlights June 3, 2026

  2. Slide 2: Safe Harbor and Non-GAAP Measures

    Safe Harbor and Non-GAAP Measures This Presentation contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995 as contained in Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amend

  3. Slide 3: First Quarter 2026 Financial Highlights

    First Quarter 2026 Financial Highlights Continued Execution in Q1, Exceeding Outlook:  Solid start to 2026, including return to positive comparable sales growth  Net sales increased 0.2%, with comparable sales growth of 0.7%  Operating income increased 50.5% to $24.6M and operating margin expande

  4. Slide 4: Pivoting to Growth in 2026: Reach for the Sky

    Pivoting to Growth in 2026: Reach for the Sky Reach for the Sky in 2026 is About Looking Up and Driving Forward  Vision: To leverage our differentiated omni-channel model to bolster competitive positioning, increase relevance and drive sales growth Offer Product Newness and Differentiation:  Innov

  5. Slide 5: We Continued to Make Progress within our Four Growth Pillars in Q1

    We Continued to Make Progress within our Four Growth Pillars in Q1 Compelling Product Trusted Stores Experience  Strength in cat contributed to improvement in consumables  Gave groomers access to customer food purchasing data to allow for more cross  Continue to lead in fresh/frozen, and shopping

  6. Slide 6: Q1 2026 Net Sales & Comp

    Q1 2026 Net Sales & Comp PERCENT OF SALES BY CATEGORY ($ in millions) Services & Q1'25 Services & Q1'26 Other Other 17% 18% $251.5 $268.6 Consumables Consumables $748.1 $746.8 50% 50% $481.3 $493.8 Supplies & Supplies & CA CA 33% 32% Q1’25 Q2’25 Q3’25 Q4’25 Q1’26 (2.3%) (2.3%) (3.1%) (2.4%) 0.2% Rev

  7. Slide 7: Q1 2026: Improving Profitability and Liquidity

    Q1 2026: Improving Profitability and Liquidity OPERATING INCOME ADJUSTED EBITDA1 ($ in millions) ($ in millions) $89.4 $97.3 $24.6 $16.4 Q1'25 Q1'26 Q1'25 Q1'26 Operating Margin 1.1% 1.6% Adj. EBITDA Margin1 6.0% 6.5% NET DEBT1 & LIQUIDITY 2 FREE CASH FLOW1 ($ in millions) Q1’25 Q1’26 YoY % Change N

  8. Slide 8: Reaffirms Full Year 2026 Outlook

    Reaffirms Full Year 2026 Outlook Full Year 2026 Outlook Net Sales Flat to 1.5% Adjusted EBITDA1 $415M to $430M Net Interest Expense ~$125M Capital Expenditures ~$140M Depreciation and ~$200M Amortization Net Store Closures 15 to 20 Full Year Outlook Considerations • Economic Conditions & Tariff Cost

  9. Slide 9: Q2 2026 Outlook

    Q2 2026 Outlook Q2 2026 Outlook Up about 0.3% year over year, Net Sales 1 in line with consensus Adjusted EBITDA 2 $110M to $112M Q2 Outlook Considerations • Economic Conditions & Tariff Costs: Assumptions in the outlook include that economic conditions, currency rates and the tax and regulatory lan

  10. Slide 10: Non-GAAP Measures and Other Definitions

    Non-GAAP Measure and Other Definitions

  11. Slide 11: Non-GAAP Measures and Other Definitions

    Non-GAAP Measures and Other Definitions The following information provides definitions and reconciliations of the non-GAAP financial measures presented in this Presentation to the most directly comparable financial measures calculated and presented in accordance with U.S. generally accepted accounti

  12. Slide 12: Non-GAAP Measures: Adjusted EBITDA

    Non-GAAP Measures: Adjusted EBITDA* * Please see slide at the end of this Presentation for related footnotes. 12

  13. Slide 13: Non-GAAP Measures: Free Cash Flow

    Non-GAAP Measures: Free Cash Flow *Change in free cash flow outflow driven by planned increases in capital expenditures and inventory investments 13

  14. Slide 14: Non-GAAP Measures: Net Debt

    Non-GAAP Measures: Net Debt 14

  15. Slide 15: Non-GAAP Financial Measures' Footnotes

    Non-GAAP Financial Measures’ Footnotes (1) Mexico Joint Venture EBITDA represents 50 percent of the entity’s operating results for all periods, as adjusted to reflect the results on a basis comparable to Adjusted EBITDA. In the financial statements, this joint venture is accounted for as an equity m

  16. Slide 16: ©2026 Petco Health and Wellness Company, Inc.

    ©2026 Petco Health and Wellness Company, Inc.

Petco Health and Wellness Company — Q1 2026 Earnings Presentation on 6ix